Citation: Mg. Haddock et al., NONPALPABLE, PROSTATE-SPECIFIC ANTIGEN DETECTED PROSTATIC-CARCINOMA -DISEASE OUTCOME AFTER IRRADIATION OR RADICAL PROSTATECTOMY, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 216-216
Citation: Ja. Bonner et Tf. Kozelsky, THE SIGNIFICANCE OF THE SEQUENCE OF ADMINISTRATION OF TOPOTECAN AND ETOPOSIDE, Cancer chemotherapy and pharmacology, 39(1-2), 1996, pp. 109-112
Authors:
PISANSKY TM
CHA SS
EARLE JD
DURR ED
KOZELSKY TF
WIEAND HS
OESTERLING JE
Citation: Tm. Pisansky et al., PROSTATE-SPECIFIC ANTIGEN AS A PRETHERAPY PROGNOSTIC FACTOR IN PATIENTS TREATED WITH RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER, Journal of clinical oncology, 11(11), 1993, pp. 2158-2166